Molecules 2005, 10
1167
General procedure for preparation of compounds 12a-c.
To a stirring solution of compound 11 (0.005 mole) in dioxane (25 mL) was added cuprous
chloride (0.0025 g) and the mixture was heated for a few minutes, then paraformaldehyde (0.005 mole)
and the appropriate secondary amine (0.005 mole) were added. The mixture was heated at 90°C for
two hours. After cooling, the mixture was filtered and the poured onto ice water (100 mL). The residue
was extracted with chloroform (3 x 25 mL) and purified on a column of silica gel using chloroform –
petroleum spirit as eluent. The product is oily. Yield of 12b 68% (from piperidine); IR (υ, cm-1): 3400
(N-H), 3050(C-Har), 2920, 2880 (C-Hal ), 1645 (C=N), 1560 (C=C), 1180 (C-N); UV (λmax): 305 nm.
General procedure for preparation of compound 14.
A mixture of the acid hydrazide 2 (0.01 mole) and phenyl isothiocyanate (0.01 mole) in dry C6H6
was refluxed for 6 hours. The solid material obtained on cooling was filtered off and recrystallized
from methanol to give compound 13. IR (υ, cm-1): 1680 (C=O), 1240 (C=S). A stirring mixture of
compound 13 (1 mmole) and sodium hydroxide (40 mg, 1 mmole) was refluxed for 4 hours. After
cooling, the solution was acidified with hydrochloric acid and the precipitate was filtered. The solid
5-(3-chloro-1-benzothien -2-yl-4-phenyl-4H-1,2,4-triazole-3-thiol (14) was recrystallized from ethyl
acetate. Yield: 73%; mp 240-242°C; IR (υ, cm-1): 3320 (N-H thione), 3060 (C-Har), 1635 (C=N),
1530 (C=C), 1310 (C=S thione); UV (λmax): 313 nm; 1H-NMR (δ) ppm: 3.8 (s, 1H, N-H thione), 8.3 –
8.9 (m, 9H, Ar-H); Calcd. for C16H10N3S2Cl (%): C, 55.97; H, 2.91; N, 12.44; found (%): C, 55.59; H,
3.08; N, 12.23.
References
1. a) Wahab, A.; Rao. R.P. J. Indian Chem. Soc. 1978, 55, 389-392; b) Sengupta, A.K.; Bajaj, O. P.
ibid 1978, 55, 108-110.
2. Dash, B.; Mahapatra, P.K.; Panda, D.; Pattnaik, J.M. J. Indian Chem. Soc. 1984, 61, 1061– 1064.
3. a) Unangst, P.C.; Shurum, G.P.; Connor, D.T.; Dyer, R.D.; Schrier, D.J. J. Med. Chem. 1992, 35,
3691–3698; b) Mullican, M.D.; Wilson, M.W.; Connor, D.T.; Kostlan, C.R.; Schrier, D.J.; Dyer,
R.D. ibid 1993, 36, 1090–1099.
4. Jones, D.H.; Slack, R.; Squires, S.; Wooldridge, K.R.H. J. Med. Chem. 1965, 8, 676 -680.
5. Sughen, J.K.; Yoloye, T. Pharm. Acta Helv. 1978, 58, 64-68.
6. a) Shams El- Dine, Sh.A.; Hazzaa, A.A.B. Pharmazie 1974, 29, 761- 768; b) Cansiz, A.; Servi,
S.; Koparir, M.; Altintas, M.; Digrak, M. J. Chem. Soc. Pak. 2001, 23, 237-239;
7. Stillings, M.R.; Welbourn, A.P.; Walter, D.Sc . J. Med. Chem. 1986, 29, 2280-2284.
8. Kane, J.M.; Dudley, M.W.; Sorensen, S.M.; Miller, F.P. J. Med.Chem. 1988, 3, 1253-1258.
9. Vamvakides, A. Pharm. Fr. 1990, 48, 154-159.
10. Parkey, S.; Castle, N. J. Heterocyclic Chem. 1986, 23, 1571-1577.
11. Shafiee, A.; Naum, E.P.; Foroumadi, M.A.; Shekan, M. J. Heterocyclic Chem. 1995, 32, 1235-
1239.
12. Shafiee, A.; Yazdikarimy, B.; Sadri, S. J. Heterocyclic Chem. 1989, 6, 1342-1343.
13. Lancelot, J.C.; Moune, D.; Robba, M. J. Heterocyclic Chem. 1980, 17, 625–629.